Experience

• • Park Square Capital in the formation of Park Square Capital Partners V, a €4 billion junior capital fund.
  • Mayfair Equity Partners in the formation of Mayfair Fund III, a £500 million fund.
  • StepStone Group in a multi-asset secondary transaction with Gyrus Capital involving Essential Pharma and dss+, both initially acquired by Gyrus Capital in 2019.